APM
EXAS

Avidity Partners Management’s Exact Sciences EXAS Stock Holding History

Avidity Partners Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-73,600
Closed -$4.03M – 47
2025
Q3 		$4.03M Sell
73,600
-281,400
-79% -$14.1M 0.92% 29
2025
Q2 		$18.9M Buy
355,000
+2,000
+0.6% +$102K 3.76% 5
2025
Q1 		$15.3M Sell
353,000
-250,011
-41% -$12.7M 2.91% 9
2024
Q4 		$33.9M Buy
603,011
+15,011
+3% +$934K 3.33% 5
2024
Q3 		$40.1M Buy
588,000
+249,500
+74% +$14.1M 2.04% 19
2024
Q2 		$14.3M Buy
+338,500
New +$18.6M 0.61% 58
2021
Q4 		– Sell
-369,000
Closed -$35.2M – 101
2021
Q3 		$35.2M Sell
369,000
-221,000
-37% -$23.3M 0.78% 42
2021
Q2 		$73.3M Sell
590,000
-8,000
-1% -$955K 1.98% 14
2021
Q1 		$78.8M Buy
598,000
+351,000
+142% +$48M 2.18% 13
2020
Q4 		$32.7M Buy
+247,000
New +$29.9M 1.06% 36
2020
Q1 		– Sell
-31,000
Closed -$2.87M – 57
2019
Q4 		$2.87M Buy
+31,000
New +$2.73M 1.81% 26

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Avidity Partners Management's EXAS Position: Q4 2025 in Review

Avidity Partners Management sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 73,600 shares — an estimated $4.03M sold.

Avidity Partners Management first reported a position in EXAS in Q4 2019 and held it in 11 quarters. The position peaked at $78.8M in Q1 2021. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Avidity Partners Management reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Avidity Partners Management sold 73,600 Exact Sciences shares in Q4 2025, an estimated $4.03M.
  • Avidity Partners Management first reported a position in Exact Sciences in Q4 2019 and held it in 11 quarters.
  • Avidity Partners Management's Exact Sciences position peaked at $78.8M in Q1 2021.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Avidity Partners Management's 13F filing for Q4 2025, filed 13 Feb 2026.